SCHEMBL5753191

SCHEMBL5753191

Cc1cccc(-n2nnc(C(C)Sc3nnc(-c4ccncc4)n3C3CC3)n2)c1.Cc1cccc(-n2nnc(CSc3nnc(-c4ccncc4)n3C3CC3)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.43
ALPL P05186 1/20 0.40
ALPI P09923 1/20 0.40
TP53 P04637 1/20 0.39
GAA P10253 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37
TSHR P16473 1/20 0.36
PTK2 Q05397 2/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
GRM5 P41594 1/20 0.34
POLB P06746 1/20 0.33
NTRK1 P04629 1/20 0.33
NTRK2 Q16620 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2893692 0.93 ALPL (0.41) CYP3A4ALPLALPITP53GAA
SCHEMBL2895597 0.91 CYP3A4 (0.49) CYP3A4ALPLALPITP53GAA
SCHEMBL2897581 0.84 MAPK1 (0.40) CYP3A4ALPLALPIGAAKMT2A
SCHEMBL5485045 0.83 DRD2 (0.34) CYP3A4ALPLALPIKMT2AMEN1
SCHEMBL2895705 0.82 CYP3A4 (0.52) CYP3A4ALPLALPITP53GAA
SCHEMBL2895698 0.82 CHRNB2 (0.41) CYP3A4ALPLALPIGAAKMT2A
SCHEMBL2895530 0.80 CYP3A4 (0.46) CYP3A4ALPLALPIGAAKMT2A
SCHEMBL5739564 0.79 CYP3A4 (0.42) CYP3A4ALPLALPIGAAKMT2A
SCHEMBL2889757 0.79 GRM5 (0.46) GAAKMT2AMEN1RXFP1TSHR
SCHEMBL2893164 0.77 GAA (0.36) CYP3A4ALPLALPIGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1716125-A1 TETRAZOLE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONITS AstraZeneca AB (SE) 2006-11-02 EP disclosed
WO-2005080356-A1 TETRAZOLE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONITS ASTRAZENECA AB (SE) 2005-09-01 WO disclosed